SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-001694
Filing Date
2019-02-01
Accepted
2019-02-01 16:19:23
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 mnlo-s3.htm S-3 653046
2 EX-1.2 mnlo-ex12_176.htm EX-1.2 280520
3 EX-4.4 mnlo-ex44_36.htm EX-4.4 512357
4 EX-5.1 mnlo-ex51_34.htm EX-5.1 55838
5 EX-12.1 mnlo-ex121_59.htm EX-12.1 9180
6 EX-23.1 mnlo-ex231_35.htm EX-23.1 3007
7 GRAPHIC gozirobznyxe000001.jpg GRAPHIC 4815
8 GRAPHIC gouo40rswkte000001.jpg GRAPHIC 3328
9 GRAPHIC gouo40rswkte000002.jpg GRAPHIC 58309
10 GRAPHIC gozirobznyxe000004.jpg GRAPHIC 4815
11 GRAPHIC gozirobznyxe000005.jpg GRAPHIC 3924
12 GRAPHIC gozirobznyxe000002.jpg GRAPHIC 4815
13 GRAPHIC gozirobznyxe000003.jpg GRAPHIC 3924
  Complete submission text file 0001564590-19-001694.txt   1631775
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229482 | Film No.: 19560053
SIC: 2834 Pharmaceutical Preparations